• Home>
  • Stocks>
  • Aspira Pathlab & Diagnostics Ltd Share Price
Aspira Pathlab & Diagnostics Ltd share price logo

Aspira Pathlab & Diagnostics Ltd Share Price (540788)

₹58.61.5%

as on

| Source : BSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Aspira Pathlab & Diagnostics Ltd Stock Performance

as on August 22, 2025 at 4:01 PM IST

  • Day's Low

    Day's High

    ₹58.5
    ₹62.45
    downward going graph

    0.17%

    Downside

    6.57%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹30
    ₹106.78
    downward going graph

    48.81%

    Downside

    82.22%

    Upside

    downward going graph
Previous Close₹59.49
Open₹62.45
Volume1,543.00
Upper Circuit₹62.46
Lower Circuit₹56.52
Day's Low58.5
Day's High62.45
52 Week Low30
52 Week High106.78
1 Month Return+ 2.71 %
3 Month Return+ 1.66 %
1 Year Return+ 85.96 %
3 Year Return+ 8.76 %
5 Year Return+ 183.29 %

Aspira Pathlab & Diagnostics Ltd Stock Fundamentals & Key Indicators

Check Aspira Pathlab & Diagnostics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹61.23 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

25.53

Return on capital employed (ROCE)

0

Industry PE ratio

54.03

Beta (LTM)

0.49

P/B Ratio

6.11

Dividend Yield

0

PEG Ratio

7.36

Quarterly Earnings Growth YOY

740

EPS (TTM)

0

Sector

Healthcare

Book Value

0

Technical Analysis

Aspira Pathlab & Diagnostics Ltd Stock's Interest Amongst Investors

-26%

Period Aug 23, 2025 to Jul 24, 2025. Change in 30 Days vs previous period

Search interest for Aspira Pathlab & Diagnostics Ltd Stock has decreased by -26% in the last 30 days, reflecting a downward trend in search activity.

Aspira Pathlab & Diagnostics Ltd Stock Valuation

Track how Aspira Pathlab & Diagnostics Ltd P/E has moved over time to understand its valuation trends.

Aspira Pathlab & Diagnostics Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-433.33x)

November 29, 2024

Today (25.53x)

August 21, 2025

Industry (54.03x)

August 21, 2025

Highest (124.02x)

March 24, 2025

LowHigh

Today’s Price to Earnings Ratio: 25.53x

Aspira Pathlab & Diagnostics Ltd Financial Results

Get the annual and quarterly financial summary of Aspira Pathlab & Diagnostics Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26
Revenue

(in ₹ Cr)

5 (0%)6 (33%)5 (12%)6 (7%)5 (9%)
Net Income

(in ₹ Cr)

0 (0%)1 (1880%)0 (69%)1 (119%)0 (38%)
Net Profit Margin1.08% (0%)16.02% (1383%)5.73% (64%)11.76% (105%)8.00% (32%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

12 (0%)18 (54%)17 (4%)15 (15%)
Total Liabilities

(in ₹ Cr)

3 (0%)4 (67%)4 (19%)3 (4%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

-2 (0%)6 (403%)2 (64%)-0 (100%)1 (10600%)

Aspira Pathlab & Diagnostics Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Aspira Pathlab & Diagnostics Ltd.

  • Aspira Pathlab & Diagnostics Ltd Earnings Results

    Aspira Pathlab & Diagnostics Ltd’s net profit jumped 740% since last year same period to ₹0.42Cr in the Q1 2025-2026. On a quarterly growth basis, Aspira Pathlab & Diagnostics Ltd has generated -38.24% fall in its net profits since last 3-months.

    Read More about Earnings Results

Aspira Pathlab & Diagnostics Ltd Stock Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Aspira Pathlab & Diagnostics Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
18.39%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
81.61%
0.00
Others
0%
0.00

Aspira Pathlab & Diagnostics Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Aspira Pathlab & Diagnostics Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA61.2336.66%0.00-313
NA26.34-16.78%0.00124
NA100.3040.11%0.5910199
NA81.857.43%0.00433
NA9.5520.44%0.00-24

Aspira Pathlab & Diagnostics Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Aspira Pathlab & Diagnostics Ltd.

  • Aspira Pathlab Reports Profit Growth in Q1 2025 - 17 May, 2025

    Aspira Pathlab & Diagnostics reported a consolidated net profit of Rs 0.68 crore for the March 2025 quarter, a turnaround from a net loss of Rs 0.50 crore in the previous quarter. Sales surged 51.31% to Rs 5.78 crore, with a 66.67% increase in annual sales to Rs 22.00 crore compared to the previous year.

Insights on Aspira Pathlab & Diagnostics Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, Aspira Pathlab has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Max Healthcare Institute Ltd has given 231.6% return, outperforming this stock by 222.8%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 81.61% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 18.39% of holdings in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, Aspira Pathlab stock has moved down by -4.1%

About Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab Diagnostics Limited is a public limited company established in July 03rd 1973, specializing in pathology investigation services, radiology investigation services and other related healthcare services at their Diagnostic Centres in Mumbai. The Company increased its paid-up capital from 5193000 equity shares of Rs. 10/ each to 136930000 divided into 8193000 equity shares and 5500000 Non-Cumulative Non-convertible Non-Participating Redeemable Preference Shares of Rs. 10/ each during 2018-19 and got its delisting approval from Metropolitan Stock Exchange of India Limited and Calcutta Stock Exchange Limited on 12th April 2018 and 15th October 2018 respectively. During the year 2016, they acquired the running business of Ankur Pathology Laboratory and issued 2943000 equity shares of Rs. 10/ each for Rs. 17/ per share, including a share premium of Rs. 7/ per share on a preferential basis to promoters. In order to widen their reach, they applied to the BSE Limited in 2017 for its listing and trading. Their registered office was shifted from West Bengal to Maharashtra and then - from within Mumbai city limits in 2017.

Revenue: ₹5.25Cr as on June 2025 (Q1 FY26)
Net Profit: ₹0.42Cr as on June 2025 (Q1 FY26)
Chairperson Name: Haseeb Drabu
OrganisationAspira Pathlab & Diagnostics Ltd
HeadquartersMumbai
IndustryHealthcare
CEOHaseeb Drabu
E-voting on sharesClick here to vote

FAQs

What is Aspira Pathlab & Diagnostics Ltd share price today?

Aspira Pathlab & Diagnostics Ltd share price today stands at ₹58.6, Open: ₹62.45, Previous Close: ₹59.49, High: ₹62.45, Low: ₹58.5, 52 Week High: ₹106.78, 52 Week Low: ₹30 as on .

How to buy Aspira Pathlab & Diagnostics Ltd shares ?

To buy Aspira Pathlab & Diagnostics Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 540788 or Aspira Pathlab & Diagnostics Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Aspira Pathlab & Diagnostics Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is today's traded volume of Aspira Pathlab & Diagnostics Ltd?

Today's traded volume of Aspira Pathlab & Diagnostics Ltd is 1,543.00. Which means that 1,543.00 shares of Aspira Pathlab & Diagnostics Ltd were bought and sold on the stock market during today's trading session.

What is Aspira Pathlab & Diagnostics Ltd's market cap today?

Today's market capitalisation of Aspira Pathlab & Diagnostics Ltd is ₹61.23 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Aspira Pathlab & Diagnostics Ltd?

Aspira Pathlab & Diagnostics Ltd’s 52 week high is ₹106.78 and 52 week low is ₹30. The current share price of Aspira Pathlab & Diagnostics Ltd is ₹58.6, which is -45.12% down from its 52 week high and 95.33% up from its 52 week low.